| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue |
-
| 362,090 | 216,605 | | Cost of Revenue |
-
| 175,568 | 109,900 | | | Gross Profit |
-
| 186,522 | 106,705 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,605 | 126,850 | 84,914 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,605) | 59,672 | 21,791 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,013 | 209 | 1,575 | | Earnings Before Interest And Taxes | (99,207) | 59,881 | 23,366 | | Interest Expense | 1,342 | 6,354 | 1,896 | | Income Before Tax | (100,549) | 53,527 | 21,470 | | Income Tax Expense |
-
| 7,855 | 1,596 | | Minority Interest |
-
| (11) |
-
| | | | Net Income From Continuing Ops | (100,549) | 45,661 | 19,874 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (100,549) | 45,661 | 19,874 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($100,549) | $45,661 | $19,874 |
|
1.23% Nasdaq 
Income Statement
